Transdermal Drug Delivery Systems and 505(b)(2) / Hybrid Regulatory Pathways.
Transdermal drug delivery systems, also named as “patches”, are controlled release dosage forms designed to deliver a therapeutically effective amount of drug through the skin during the time of application of the product, which may vary between 9 h (methylphenidate) to 148 h (buprenorphine). [...]